cy 208-243 has been researched along with naltrexone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Markó, M; Siegel, RA | 1 |
1 other study(ies) available for cy 208-243 and naltrexone
Article | Year |
---|---|
Hypothalamo-hypophyseal-gonadal function in the rat following administration of the novel and selective D-1 agonist CY 208-243.
Topics: Animals; Dopamine Antagonists; Female; Hypothalamo-Hypophyseal System; Indoles; Luteinizing Hormone; Male; Naltrexone; Ovulation; Phenanthridines; Rats; Receptors, Dopamine | 1988 |